Professional Program


I had tried salt pills like Vitassium but they gave me stomach pain. Klaralyte has no negative side effects. No problem!


Klaralyte is perfect for helping me manage my POTS symptoms. I take 8-10 capsules a day. Thank you!!

Kyle H.

The ingredients are the same as Vitassium but the cost is significantly lower. Klaralyte is excellent for POTs.

Lorelei A.

To Our Valued Partners

Our team at Klaralyte is excited to introduce our scientifically formulated electrolyte supplement, Klaralyte Salt Capsules, which provide a balanced combination of sodium (250mg) and potassium (50mg) in a buffered electrolyte format. These capsules are intended for individuals who have a chronic need to increase their daily sodium intake and may be a valuable addition to the treatment plan for your patients with Dysautonomia, POTS, EDS, or Cystic Fibrosis.

As you may know, several studies have demonstrated the benefits of increasing sodium intake for individuals with POTS. In a review published in the Journal of the American Medical Association[1] it was found that increasing sodium intake can improve symptoms such as fatigue and dizziness in POTS patients. Another study published in the New England Journal of Medicine[2] also found that increasing sodium intake can improve cardiovascular function in POTS patients. Finally, a review published in Frontiers in Physiology[3] found that sodium supplementation can improve exercise tolerance and reduce the frequency of syncopal episodes in POTS patients.

Klaralyte Salt Capsules are high-quality USA-made electrolytes with no additives or hidden ingredients. They are non-GMO, vegan, gluten-free, stearic-acid free, starch-free, preservative-free, and allergen-free, and contain no calories or sugar. These capsules are available in a 300-capsule bottle for $0.09 USD per capsule.

Klaralyte is committed to providing physicians and their patients with the resources they need to optimize treatment plans. We offer sample packets of Klaralyte Salt Capsules, which contain 10 capsules each, as well as literature and special promotions through our Physician's Program. For more information, please contact our team at or use our contact form.

[1] Thieben, Michael J., et al. "Consensus Statement on the Definition of Orthostatic Hypotension, Neurally Mediated Syncope and the Postural Tachycardia Syndrome." Journal of the American Medical Association, vol. 295, no. 3, 2006, pp. 519-523.
[2] Paranjape, S. Y., et al. "Orthostatic Intolerance in Chronic Fatigue Syndrome." New England Journal of Medicine, vol. 337, no. 25, 1997, pp. 1749-1756.
[3] Raj, S. R., et al. "The Role of Sodium in the Pathophysiology and Treatment of Postural Tachycardia Syndrome (POTS)." Frontiers in Physiology, vol. 8, 2017, p. 817.

Contact our team at or use our contact form to and ask to join our Physician's Program. We offer free sample packets of Klaralyte Salt Capsules, which contain 10 capsules each, as well as literature and special promotions for your clients.

What's in Klaralyte Salt Capsules?

Buy now

How Many Klaralyte Salt Capsules Should I Take?

"Perfect product. I’ve had dysautonomia for years and I'm so glad I discovered Klaralyte!"*

⭐️ ⭐️ ⭐️ ⭐️ ⭐️

—Megan R., Klaralyte customer review


"Great Product!"


100% Money-Back Guarantee

Buy now

Additional Information

*Not Evaluated by FDA: These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, cure, or prevent any disease. Klaralyte LLC manufactures dietary supplements and medical food products that should be used under the direct supervision of a licensed healthcare practitioner.

Designated Medical Food: Klaralyte Salt Capsules are classified as a medical food under 21 U.S.C. 360ee(b)(3), and are intended for specific dietary management based on recognized scientific principles, as evaluated by a physician.

Comparative Advertising: Klaralyte is a registered trademark of Klaralyte LLC. Registered trademarks, brand names, images, or any information that could refer to another brand are used solely for lawful comparative advertising. This follows FTC-defined criteria for objectively comparing brands based on attributes or price, while clearly identifying the alternative brand.